Latest Asx News

St Barbara Limited has announced its intention to separate its Atlantic Gold Operations in Nova Scotia, aiming to unlock value through a Canadian-led development while concentrating on its Papua New Guinea assets.

St Barbara reveals plans to expand its 15-Mile processing plant capacity from 2.1 Mtpa to 3.0 Mtpa, integrating Cochrane Hill ore to target annual gold production exceeding 100,000 ounces.

Horizon Minerals has commenced processing the first ore from its Phillips Find Gold Project, marking a key milestone in its path to gold production. The joint venture with BML Ventures is progressing well, with mining operations already delivering substantial volumes.

Vection Technologies has secured a three-year, AUD$575k partnership with global insurer Generali to deploy AI-driven extended reality solutions enhancing workplace safety and client engagement.

Finder Energy reports excellent progress on its Ikan 3D seismic reprocessing project, with imaging results exceeding expectations and the project on track for completion by end Q1 2025. The enhanced data aims to optimise development wells and de-risk exploration targets, potentially unlocking significant value.

IMDEX Limited has announced a fully franked ordinary dividend of AUD 0.015 per share, signaling steady shareholder returns for the half-year ending December 2024.

IMDEX reported a 10% revenue decline in 1H25 amid subdued global exploration activity but delivered a robust 28% increase in EBITDA, maintaining a strong 30% margin and positioning itself for growth.

Red Mountain Mining's recent desktop study of the Fry Lake Gold Project reveals promising gold mineralisation across multiple claims, setting the stage for an active 2025 exploration season amid soaring gold prices.

Lefroy Exploration has partnered with BML Ventures under a profit-sharing agreement to develop the Lucky Strike gold deposit, aiming to start mining operations in the second half of 2025. This collaboration leverages BML's mining expertise and funding, while Lefroy retains half the profits from the project.

EMVision Medical Devices has secured US ethics approval for its pivotal multi-centre trial of the EMVision emu™ brain scanner, paving the way for a March 2025 trial start aimed at FDA clearance.

Suncorp Group Limited has announced a cash return of capital of AUD 3.00 per share, backed by shareholder and regulatory approvals, with payments scheduled for early March 2025.

Suncorp Group Limited has outlined a detailed timetable for its capital return, share consolidation, and dividend payments, marking a significant phase in its capital management strategy.